Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
K. Swinnen (Leuven, Belgium), K. Verstraete (Leuven, Belgium), N. Das (Leuven, Belgium), M. Topalovic (Leuven, Belgium), R. Quarck (Leuven, Belgium), C. Belge (Leuven, Belgium), W. Janssens (Leuven, Belgium), M. Delcroix (Leuven, Belgium). Clinically applicable machine learning prediction model for pulmonary hypertension due to left heart disease. 175

Member's Comments

No comment yet.

Related content which might interest you: Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017 Year: 2018 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 How to define pulmonary hypertension due to left heart disease Source: Eur Respir J 2016; 48: 553-555 Year: 2016 A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease Source: Eur Respir J, 54 (3) 1802435; 10.1183/13993003.02435-2018 Year: 2019 Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012 Under pressure: pulmonary hypertension associated with left heart disease Source: Eur Respir Rev 2015; 24: 665-673 Year: 2015 Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure Source: Eur Respir J 2015; 46: 619-621 Year: 2015 Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 The haemodynamic and gas-exchange responses to exercise in pulmonary hypertension, chronic obstructive pulmonary disease and left heart ventricle failure: similarities and differences Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Pulmonary hypertension due to left heart disease Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018 Year: 2019 Sex bias exists in diagnosing pulmonary arterial hypertension via machine learning Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 Applying machine learning and pulmonary function data to detect interstitial lung disease in systemic sclerosis. Source: International Congress 2017 – Best abstracts in lung function Year: 2017 Diagnosis of pulmonary hypertension from MR image based computational models of pulmonary vascular haemodynamics and decision tree analysis Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Efficacy of exercise training in congenital heart disease associated pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012